Status:
COMPLETED
Optimizing Soft Speech Recognition in Children With Hearing Loss
Lead Sponsor:
Sonova AG
Collaborating Sponsors:
Hearts for Hearing
Conditions:
Hearing Loss, Sensorineural
Hearing Loss, Bilateral
Eligibility:
All Genders
4-12 years
Phase:
NA
Brief Summary
Overhearing is important for vocabulary learning and speech and language development in young children. However, contemporary hearing aids are generally unable to provide adequate access to low-level ...
Detailed Description
The primary objective of this study is to evaluate whether soft speech recognition in quiet is significantly improved with Speech Enhancer (SE) "on" at the default setting (moderate) compared to Speec...
Eligibility Criteria
Inclusion
- native English speakers who communicate verbally
- no known speech language disorders, cognitive or learning issues
- experienced hearing aid users (\> 6 months use)
- "full-time" hearing aid users (i.e., wear on a daily basis)
- CNC word scores of 30% or better at 50dBA in quiet with SE "off"
Exclusion
- new hearing aid users
- inconsistent hearing aid users
- \<4 years or \>12 years of age
- non-native English speaker who communicates verbally
- known cognitive/ learning issues or speech language disorder
- CNC word scores \< 30% correct presented at 50dBA in quiet with SE "off"
Key Trial Info
Start Date :
March 21 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 14 2022
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT05299892
Start Date
March 21 2022
End Date
October 14 2022
Last Update
December 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hearts for Hearing
Oklahoma City, Oklahoma, United States, 73120